Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells
Open Access
- 26 June 2026
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 7 (7) , 102889
Abstract
No abstract availableKeywords
Funding Information
- V Foundation for Cancer Research
- U.S. Department of War
- Commonwealth Fund
- National Institute of General Medical Sciences
- Conquer Cancer Foundation
- National Cancer Institute
This publication has 45 references indexed in Scilit:
- CD4+CD8+ double-positive T cells in immune disorders and cancer: Prospects and hurdles in immunotherapyAutoimmunity Reviews, 2025
- Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancerCancer Cell, 2024
- Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapyCell, 2022
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerCancer Cell, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading systemCancer Medicine, 2020
- Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profileCancer Immunology, Immunotherapy, 2019
- Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemiaMedical Oncology, 2012
- The immunosuppressive tumor microenvironment in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2008
- Cytofluorometric Identification of Two Populations of Double Positive (CD4+,CD8+) T Lymphocytes in Human Peripheral BloodBiochemical and Biophysical Research Communications, 1993